Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emboshield and Xact Post Approval Carotid Stent Trial Using the Emboshield® BareWire™ Rapid Exchange Embolic Protection System and Xact® Rapid Exchange Carotid Stent System

NCT00287508 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT00287508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00287508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emboshield and Xact Post Approval Carotid Stent Trial Using the Emboshield® BareWire™ Rapid Exchange Embolic Protection System and Xact® Rapid Exchange Carotid Stent System
Lead sponsor
Abbott Medical Devices
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2005
Completion date
January 31, 2008
Enrollment
1,500
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, carotid artery disease, carotid stenosis, stroke